20210119 – ANSM Approval BT-001 EN
Category: Press release
Transgene Appoints Gaëlle Stadtler as Director of Human Resources
20210114 Transgene – Appointment Gaelle Stadtler_EN
Transgene and BioInvent receive CTA approval for Phase 1/2a trial of oncolytic virus BT-001 in solid tumors
20201221 – CTA Approval BT-001 – EN
Transgene Announces Financial Calendar for 2021
20191217 Financial calendar 2021 EN
Transgene Announces Investor Meetings for January 2021
20201216 PR Investors Meeting agenda Jan 2021
Transgene to present Phase 1b/2 trial results of TG4001 in combination with avelumab in advanced HPV-positive cancers at ESMO IO 2020
20201203 – TG4001 mini oral prez ESMO IO EN
Transgene appoints Hedi Ben Brahim as Chairman and Chief Executive Officer
20201203 – Nomination Transgene – EN
Transgene and BioInvent present data on next generation oncolytic virus BT-001 at the SITC 35th Anniversary Annual Meeting
20201109 Transgene BioInvent_SITC BT001_EN
Transgene presents e-poster outlining detailed results from the Phase 1b/2 trial of TG4001 in combination with avelumab in advanced HPV-positive cancers at SITC 2020
20201109 – TG4001+avelumab presentation poster SITC – EN
Transgene reports business update and end Q3 2020 financial position
20201105 Transgene Q3 business upradta EN